Trials / Recruiting
RecruitingNCT05769517
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
Prediction of Germline BRCA 1/2 Genes Pathogenetic Variants From Healthy Ovaries Ultrasound Images: Radiogenomics as an Innovative Tool to Prevent BRCA-related Cancers
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,300 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
The project aims at enhancing performance metrics and prospectively validating a radiogenomics model based on ovarian US images for predicting germline breast cancer susceptibility gene 1 and/or 2 (BRCA) status in women with healthy ovaries. The project is divided in two operational phases: Retrospective phase AIM 1: To define and implement a proper and fine-tuned image preprocessing pipeline on the existing dataset; AIM 2: To enlarge dataset size with new real images from different centers and apply data augmentation techniques, deep neural network models combined with the aforementioned handcrafted imaging features from radiomics analysis; Prospective phase AIM 3: To further cross-validate the predictive model on US images acquired prospectively in an observational multicenter study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Germinal BRCA | We will conduct a multicenter prospective observational study aimed at automatically implementing the predictive model and collecting US images of healthy ovaries from patients tested for germline BRCA pathogenetic variants according to current indications. |
Timeline
- Start date
- 2023-03-20
- Primary completion
- 2024-04-01
- Completion
- 2031-03-08
- First posted
- 2023-03-15
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05769517. Inclusion in this directory is not an endorsement.